Head and Neck TumorsHead and Neck TumorsОпухоли головы и шеи2222-14682411-4634Publishing House ABV Press24610.17650/2222-1468-2016-6-4-19-25DIAGNOSIS AND TREATMENT OF HEAD AND NECK TUMORSДИАГНОСТИКА И ЛЕЧЕНИЕ ОПУХОЛЕЙ ГОЛОВЫ И ШЕИSURGICAL TREATMENT OF HEAD AND NECK CUTANEOUS MELANOMA: A MODERN APPROACH TO THE PROBLEMОСОБЕННОСТИ ХИРУРГИЧЕСКОГО ЛЕЧЕНИЯ МЕЛАНОМЫ КОЖИ ГОЛОВЫ И ШЕИ. СОВРЕМЕННЫЙ ВЗГЛЯД НА ПРОБЛЕМУPakM. B.ПакМ. Б.
Russian Federation

Department of Oncology, Medical Faculty.

Build. 2, 8 Trubetskaya St., Moscow 119991

Максим Бокманович Пак - кафедра онкологии лечебного факультета.

119991 Москва, ул. Трубецкая, 8, стр. 2, mbpak@yandex.ru

mbpak@yandex.ruMudunovA. M.МудуновА. М.
Russian Federation

Department of Oncology, Medical Faculty.

Build. 2, 8 Trubetskaya St., Moscow 119991; 23 Kashirskoe Shosse, Moscow 115478

Кафедра онкологии лечебного факультета ПМГМУ.

119991 Москва, ул. Трубецкая, 8, стр. 2; 115478 Москва, Каширское шоссе, 23

DemidovL. V.ДемидовЛ. В.
Russian Federation

Department of Oncology, Medical Faculty FMSMU

Build. 2, 8 Trubetskaya St., Moscow 119991; 23 Kashirskoe Shosse, Moscow 115478

Кафедра онкологии лечебного факультета ПМГМУ.

119991 Москва, ул. Трубецкая, 8, стр. 2; 115478 Москва, Каширское шоссе, 23

AzizyanR. I.АзизянР. И.
Russian Federation

23 Kashirskoe Shosse, Moscow 115478

115478 Москва, Каширское шоссе, 23

BrzhezovskiyV. Zh.БржезовскийВ. Ж.
Russian Federation

23 Kashirskoe Shosse, Moscow 115478

115478 Москва, Каширское шоссе, 23

StelmakhD. K.СтельмахД. К.
Russian Federation

23 Kashirskoe Shosse, Moscow 115478

115478 Москва, Каширское шоссе, 23

UtyashevI. А.УтяшевИ. А.
Russian Federation

23 Kashirskoe Shosse, Moscow 115478

115478 Москва, Каширское шоссе, 23

AgabekyanG. O.АгабекянГ. О.
Russian Federation

23 Kashirskoe Shosse, Moscow 115478

115478 Москва, Каширское шоссе, 23

I.M. Sechenov First Moscow State Medical UniversityПервый Московский государственный медицинский университет имени И.М. СеченоваN.N. Blokhin Russian Cancer Research CenterРоссийский онкологический научный центр имени Н.Н. Блохина081220166419250804201708042017Copyright ©; 2016, Pak M.B., Mudunov A.M., Demidov L.V., Azizyan R.I., Brzhezovskiy V.Z., Stelmakh D.K., Utyashev I.А., Agabekyan G.O.Copyright ©; 2016, Пак М.Б., Мудунов А.М., Демидов Л.В., Азизян Р.И., Бржезовский В.Ж., Стельмах Д.К., Утяшев И.А., Агабекян Г.О.2016Pak M.B., Mudunov A.M., Demidov L.V., Azizyan R.I., Brzhezovskiy V.Z., Stelmakh D.K., Utyashev I.А., Agabekyan G.O.Пак М.Б., Мудунов А.М., Демидов Л.В., Азизян Р.И., Бржезовский В.Ж., Стельмах Д.К., Утяшев И.А., Агабекян Г.О.https://creativecommons.org/licenses/by/4.0https://ogsh.abvpress.ru/jour/article/view/246

Cutaneous melanoma (CM) is a highly aggressive malignant tumor. The incidence of CM is 1–4 % of all cancers and 3–5 % of all malignant neoplasms of the skin. According to different authors, CM is localized in the area of head and neck (H&N) in 22–46 %. Despite revolutionary discoveries in recent years in the treatment of metastatic melanoma, the main treatment option of primary СМ is still surgery. However, the question about the size of surgical margins and tissue sparing excision is still pending, particularly in the area of the head and neck. Despite the possibilities of modern methods of revealing of metastases in lymph nodes (LN),  diagnosis of “latent” metastases in LN and further tactics of treatment remains the matter of argument. The purpose of this publication is to review the literature on the current problem in the surgical treatment of СМ of the H&N.

This article is the result of analysis of publication devoted to surgical treatment and diagnosis of СМ metastases in the LN of the H&N.

cutaneous melanomahead and neckoverall survivalsurgical marginswide excisionsentinel lymph nodeмеланома кожиголова и шеяобщая выживаемостьхирургический отступширокое иссечениесторожевой лимфатический узел1. Двойрин В.В., Церковный Г.Ф., Аксель Е.М. Заболеваемость населения СССР злокачественными новообразованиями (1985–1989 гг.). Вопросы онкологии 1991;(4):401–36. [Dvoyrin V.V., Tserkovnyy G.F., Aksel’ E.M. Morbidity of malignant neoplasms of the USSR (1985–1989). Voprosy onkologii = Oncology Issues 1991;(4):401–36. (In Russ.)].Двойрин В.В., Церковный Г.Ф., Аксель Е.М. Заболеваемость населения СССР злокачественными новообразованиями (1985–1989 гг.). Вопросы онкологии 1991;(4):401–36. [Dvoyrin V.V., Tserkovnyy G.F., Aksel’ E.M. Morbidity of malignant neoplasms of the USSR (1985–1989). Voprosy onkologii = Oncology Issues 1991;(4):401–36. (In Russ.)].2. Пачес А.И., Бржезовский В.Ж., Демидов Л.В. и др. Опухоли головы и шеи: клинические рекомендации. М.: Практическая медицина, 2013. С. 60–9. [Paches A.I., Brzhezowskiy V.Zh., Demidov L.V. et al. Tumors of the head and neck: clinical guidelines. Moscow: Prakticheskaya meditsina, 2013. Pp. 60–9. (In Russ.)].Пачес А.И., Бржезовский В.Ж., Демидов Л.В. и др. Опухоли головы и шеи: клинические рекомендации. М.: Практическая медицина, 2013. С. 60–9. [Paches A.I., Brzhezowskiy V.Zh., Demidov L.V. et al. Tumors of the head and neck: clinical guidelines. Moscow: Prakticheskaya meditsina, 2013. Pp. 60–9. (In Russ.)].3. Friedman R.J., Rigel D.S., Silverman M.K. et al. Malignant melanoma in the 1990s: the continued importance of early detection and the role of physician examination and self-examination of the skin. Cancer 1991;41(4):201–26.Friedman R.J., Rigel D.S., Silverman M.K. et al. Malignant melanoma in the 1990s: the continued importance of early detection and the role of physician examination and self-examination of the skin. Cancer 1991;41(4):201–26.4. Morton D.L., Essner R., Kirkwood J.M., Wollman R.C. Malignant Melanoma. London, 2000.Morton D.L., Essner R., Kirkwood J.M., Wollman R.C. Malignant Melanoma. London, 2000.5. Breslow A. Thickness, cross-sectional areas and depth of invasion in prognosis of cutaneous melanoma. Ann Surg 1970;172(5):902–8.Breslow A. Thickness, cross-sectional areas and depth of invasion in prognosis of cutaneous melanoma. Ann Surg 1970;172(5):902–8.6. AJCC (American Joint Committee on Cancer) Cancer Staging Hand-book: TNM Classification of Malignant Tumors. 6th edn. New York: Springer-Verlag, 2002.AJCC (American Joint Committee on Cancer) Cancer Staging Hand-book: TNM Classification of Malignant Tumors. 6th edn. New York: Springer-Verlag, 2002.7. Balch C.M., Gershenwald J.E., Soong S. et al. Final version of 2009 AJCC Melanoma Staging and Classification. J Clin Oncol 2009;27(36):6199–206. DOI: 10.1200/JCO.2009.23.4799.Balch C.M., Gershenwald J.E., Soong S. et al. Final version of 2009 AJCC Melanoma Staging and Classification. J Clin Oncol 2009;27(36):6199–206. DOI: 10.1200/JCO.2009.23.4799.8. Демидов Л.В. Изучение факторов прогноза при меланоме кожи. Дис. … канд. мед. наук. М., 1982. 188 с. [Demidov L.V. A study of factors and prognosis in cutaneous melanoma. Thesis … of candidate of medicine. Moscow, 1982. 188 p. (In Russ.)].Демидов Л.В. Изучение факторов прогноза при меланоме кожи. Дис. … канд. мед. наук. М., 1982. 188 с. [Demidov L.V. A study of factors and prognosis in cutaneous melanoma. Thesis … of candidate of medicine. Moscow, 1982. 188 p. (In Russ.)].9. Veronesi U., Casinelli N., Adarnus J. et al. Thin stage I primary cutaneous malignant melanoma: comparison of excision with margins of 1 or 3 cm. N Engl J Med 1988;318:1159–62.Veronesi U., Casinelli N., Adarnus J. et al. Thin stage I primary cutaneous malignant melanoma: comparison of excision with margins of 1 or 3 cm. N Engl J Med 1988;318:1159–62.10. Essner R. Surgical treatment of malignant melanoma. Surg Clin North Am 2003;83:109–56.Essner R. Surgical treatment of malignant melanoma. Surg Clin North Am 2003;83:109–56.11. Handley W.S. The pathology of melanotic growths in relation to their operative management. Lancet 1907;1:27.Handley W.S. The pathology of melanotic growths in relation to their operative management. Lancet 1907;1:27.12. Ames F.S., Balch C.M., Reintgen D. Loсal reccurenсes and their management. Philadelphia: JB Lippincott, 1992. 287 p.Ames F.S., Balch C.M., Reintgen D. Loсal reccurenсes and their management. Philadelphia: JB Lippincott, 1992. 287 p.13. Balch C.M., Hjugton A.N., Peters L.I. Cutaneous Melanoma. In: Principles and Practice of Oncology. Philadelphia, 1993. Pp. 1612–61.Balch C.M., Hjugton A.N., Peters L.I. Cutaneous Melanoma. In: Principles and Practice of Oncology. Philadelphia, 1993. Pp. 1612–61.14. Davis N.C. Cutaneous melanoma: The Queensland experience. Curr Probl Surg 1976;13(5):28–31.Davis N.C. Cutaneous melanoma: The Queensland experience. Curr Probl Surg 1976;13(5):28–31.15. Вагнер Р.И., Анисимов В.В. Факторы, способствующие местному рецидивированию и региональному метастазированию меланомы кожи. Тезисы докладов IV Всесоюзного съезда онкологов. Л., 1986. С. 230. [Wagner R.I., Anisimov V.V. Factors contributing to local recurrence and regional metastasis of cutaneous melanoma. Theses of reports of IV all-Union Congress of oncologists. Leningrad, 1986. P. 230. (In Russ.)].Вагнер Р.И., Анисимов В.В. Факторы, способствующие местному рецидивированию и региональному метастазированию меланомы кожи. Тезисы докладов IV Всесоюзного съезда онкологов. Л., 1986. С. 230. [Wagner R.I., Anisimov V.V. Factors contributing to local recurrence and regional metastasis of cutaneous melanoma. Theses of reports of IV all-Union Congress of oncologists. Leningrad, 1986. P. 230. (In Russ.)].16. Khayat D., Rixe O., Martin G. et al. Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1-mm thick). Cancer 2003;97(8): 1941–6.Khayat D., Rixe O., Martin G. et al. Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1-mm thick). Cancer 2003;97(8): 1941–6.17. Cohn-Cedermark G., Rutqvist L.E., Andersson R. et al. Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8–2.0 mm. Cancer 2000;89(7):1495–501.Cohn-Cedermark G., Rutqvist L.E., Andersson R. et al. Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8–2.0 mm. Cancer 2000;89(7):1495–501.18. Cascinelli N., Belli F., Santinami M. et al. Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann Surg Oncol 2000;7(6): 469–74.Cascinelli N., Belli F., Santinami M. et al. Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann Surg Oncol 2000;7(6): 469–74.19. Balch C.M., Soong S.J., Smith T. et al. Long-term results of a prospective surgical trial comparing 2 cm vs 4 cm excision margins for 740 patients with 1–4 mm melanomas. Ann Surg Oncol 2001;8(2):101–8.Balch C.M., Soong S.J., Smith T. et al. Long-term results of a prospective surgical trial comparing 2 cm vs 4 cm excision margins for 740 patients with 1–4 mm melanomas. Ann Surg Oncol 2001;8(2):101–8.20. Thomas J.M., Newton-Bishop J., Hern R. et al. Excision margins in high-risk malignant melanoma. N Engl J Med 2004;350:757–66.Thomas J.M., Newton-Bishop J., Hern R. et al. Excision margins in high-risk malignant melanoma. N Engl J Med 2004;350:757–66.21. Ringborg U., Brahme E.M., Drewiecki K. Randomized trial of a resection margin of 2 cm versus 4 cm for cutaneous malignant melanoma with a tumor thickness of more than 2 mm. World Congress on Melanoma, 6–10 September 2005. Vancouver, Canada, 2005.Ringborg U., Brahme E.M., Drewiecki K. Randomized trial of a resection margin of 2 cm versus 4 cm for cutaneous malignant melanoma with a tumor thickness of more than 2 mm. World Congress on Melanoma, 6–10 September 2005. Vancouver, Canada, 2005.22. Демидов Л.В., Утяшев И.А. Хирургическое лечение меланомы кожи. Практическая онкология 2012;13(2):125–34. [Demidov L.V., Utyashev I.A. Surgical treatment of melanoma. Prakticheskaya onkologiya = Practical Oncology 2012;13(2):125–34. (In Russ.)].Демидов Л.В., Утяшев И.А. Хирургическое лечение меланомы кожи. Практическая онкология 2012;13(2):125–34. [Demidov L.V., Utyashev I.A. Surgical treatment of melanoma. Prakticheskaya onkologiya = Practical Oncology 2012;13(2):125–34. (In Russ.)].23. Serrone L., Solivetti F.M., Thorel M.F. et al. High frequency ultrasound in the preoperative staging of primary melanoma: a statistical analysis. Melanoma Res 2002;12(3):287–90.Serrone L., Solivetti F.M., Thorel M.F. et al. High frequency ultrasound in the preoperative staging of primary melanoma: a statistical analysis. Melanoma Res 2002;12(3):287–90.24. Bessoud B., Lassau N., Koscielny S. et al. High-frequency sonography and color Doppler in the management of pigmented skin lesions. Ultrasound Med Biol 2003;29(6):875–9.Bessoud B., Lassau N., Koscielny S. et al. High-frequency sonography and color Doppler in the management of pigmented skin lesions. Ultrasound Med Biol 2003;29(6):875–9.25. Voit C., Mayer T., Kron M. et al. Efficacy of ultrasound B-scan compared with physical examination in follow-up of melanoma patients. Cancer 2000;90(3):186–93.Voit C., Mayer T., Kron M. et al. Efficacy of ultrasound B-scan compared with physical examination in follow-up of melanoma patients. Cancer 2000;90(3):186–93.26. Voit C.A., van Akkooi A.C.J., fer-Hesterberg G.S. et al. Rotterdam Criteria for Sentinel Node (SN) Tumor Burden and the Accuracy of Ultrasound (US) Guided Fine-Needle Aspiration Cytology (FNAC): Can US-Guided FNAC Replace SN Staging in Patients With Melanoma? J Clin Oncol2009;27(30):4994–5000.Voit C.A., van Akkooi A.C.J., fer-Hesterberg G.S. et al. Rotterdam Criteria for Sentinel Node (SN) Tumor Burden and the Accuracy of Ultrasound (US) Guided Fine-Needle Aspiration Cytology (FNAC): Can US-Guided FNAC Replace SN Staging in Patients With Melanoma? J Clin Oncol2009;27(30):4994–5000.27. Van den Brekel M.W., Pameijer F.A., Koops W. et al. Computed tomography for the detection of neck node metastases in melanoma patients. Eur J Surg Oncol 1998;24(1):51–4.Van den Brekel M.W., Pameijer F.A., Koops W. et al. Computed tomography for the detection of neck node metastases in melanoma patients. Eur J Surg Oncol 1998;24(1):51–4.28. Halpern B.S., Schiepers C., Weber W.A. et al. Presurgical staging of non-small cell lung cancer: positron emission tomography, integrated positron emission tomography/CT, and software image fusion. Chest 2005;128(4):2289–97.Halpern B.S., Schiepers C., Weber W.A. et al. Presurgical staging of non-small cell lung cancer: positron emission tomography, integrated positron emission tomography/CT, and software image fusion. Chest 2005;128(4):2289–97.29. Klode J., Dissemond J., Grabbe S. et al. Sentinel lymph node excision and PET-CT in the initial stage of malignant melanoma: a retrospective analysis of 61 patients with malignant melanoma in American joint committee on cancer stages I and II. Dermatol Surg 2010;36(4):439–45.Klode J., Dissemond J., Grabbe S. et al. Sentinel lymph node excision and PET-CT in the initial stage of malignant melanoma: a retrospective analysis of 61 patients with malignant melanoma in American joint committee on cancer stages I and II. Dermatol Surg 2010;36(4):439–45.30. Morton D.L., Thompson J.F., Cochran A.J. et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006;355(13):1307–17.Morton D.L., Thompson J.F., Cochran A.J. et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006;355(13):1307–17.31. Chao C., Wong S.L., Edwards M.J. et al. Sentinel lymph node biopsy for head and neck melanomas. Ann Surg Oncol 2003;10(1):21–6.Chao C., Wong S.L., Edwards M.J. et al. Sentinel lymph node biopsy for head and neck melanomas. Ann Surg Oncol 2003;10(1):21–6.32. Morton D.L., Cochran A.J., Thompson J.F. et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 2005;242(3):302–11; discussion 311–3.Morton D.L., Cochran A.J., Thompson J.F. et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 2005;242(3):302–11; discussion 311–3.33. Анисимов В.В. Меланома кожи (перспективы улучшения диагностики и лечения). Дис. … д-pa мед. наук. СПб., 2000. 97 с. [Anisimov V.V. Melanoma of the skin (the prospects for improving diagnosis and treatment). Thesis … of doctor of medicine. Saint Petersburg, 2000. 97 p. (In Russ.)].Анисимов В.В. Меланома кожи (перспективы улучшения диагностики и лечения). Дис. … д-pa мед. наук. СПб., 2000. 97 с. [Anisimov V.V. Melanoma of the skin (the prospects for improving diagnosis and treatment). Thesis … of doctor of medicine. Saint Petersburg, 2000. 97 p. (In Russ.)].34. Balch C.M., Smalley R.V., Bartolucci A. et al. A randomized prospective clinical trial of adjuvant C. parvum immunotherapy in 260 patient with clinically localized melanoma (stage I): prognostic factors analysis and preliminary results of immunotherapy. Cancer 1982;49(6):1079–84.Balch C.M., Smalley R.V., Bartolucci A. et al. A randomized prospective clinical trial of adjuvant C. parvum immunotherapy in 260 patient with clinically localized melanoma (stage I): prognostic factors analysis and preliminary results of immunotherapy. Cancer 1982;49(6):1079–84.35. Morton D.L., Wen D.R., Foshag L.J. et al. Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck. J Clin Oncol 1993;11:1751–6.Morton D.L., Wen D.R., Foshag L.J. et al. Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck. J Clin Oncol 1993;11:1751–6.36. O’Brien C.J., Uren R.F., Thompson J.F. et al. Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy. Am J Surg 1995;170:461–6.O’Brien C.J., Uren R.F., Thompson J.F. et al. Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy. Am J Surg 1995;170:461–6.